Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT versus SSRI versus combined therapy for panic disorder
NL-OMON26056Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of fluvoxamine, sertraline, citalopram and fluoxetine in panic disorder and agoraphobia (3 arms), sponsored by University Medical Center Groningen. Primary endpoints: Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale and 7 more. Started Jan 2001; status: active, not recruiting.
02
Drugs
fluvoxaminesertralinecitalopramfluoxetine
03
Conditions
panic disorderagoraphobia
Beyond the preview
Go deeper on NL-OMON26056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26056.